Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1189310

registered interest
date	22/04/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many prescriptions for cannabis-based products for medicinal use have been issued on the NHS since the rescheduling of those products.
tabling member constituency	Inverclyde
tabling member printed	Ronnie Cowan
uin	39000
answer	answer is ministerial correction date of answer 04/05/2020 answer text <p>There have been 3,546 items for licensed and unlicensed cannabis-based medicines prescribed on a National Health Service prescription, dispensed in the community in England and submitted to the NHS Business Services Authority for reimbursement for the period November 2018 to February 2020 (latest data available).</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 04/05/2020 13:01:12 answering member 4380 label Biography information for Jo Churchill
tabling member	4465 label Biography information for Ronnie Cowan

1173615

registered interest
date	27/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions officials of his Department has had with officials of the Home Office to ensure there are no undue delays in granting import licences for cannabis-based products for medicinal use; and if he will make a statement.
tabling member constituency	Inverclyde
tabling member printed	Ronnie Cowan
uin	8359
answer	answer is ministerial correction date of answer 04/02/2020 answer text <p>We are aware that some wholesalers and pharmacies have reported challenges in importing a range of unlicensed cannabis-based products for medicinal use. It is clear that for some products, long lead times and delays in receiving export licences from the authorities in the country of manufacture, have led to delays in the supply against prescriptions and pose a potential risk to patients receiving their medicines on time.</p><p>The Department, the Medicines and Healthcare products Regulatory Agency (MHRA), the Home Office, NHS England and NHS Improvement are in the process of agreeing what action can be taken to help alleviate these delays, including exploring mechanisms to allow licensed wholesalers to hold a small reserve stock linked to an evidenced demand by specialist prescribers; and ensuring that the United Kingdom meets its obligations under the Single Convention on Narcotic Drugs. Any changes will be reflected in the guidance published by the MHRA.</p><p>In the meantime, the Home Office and the MHRA are treating all import requests for cannabis-based products for medicinal use as emergency supplies and on receipt of the correct documentation, applicants can expect a decision within a few working days.</p><p>No meetings have taken place with representatives of patient groups concerning the reported delays to imports of cannabis-base products for medicinal use. Officials did meet with patient groups in the development of this policy when the previous Government rescheduled cannabis-based products for medicinal use under the Misuse of Drugs Regulations 2001.</p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 8360 8361 question first answered 04/02/2020 17:26:56 answering member 4380 label Biography information for Jo Churchill
tabling member	4465 label Biography information for Ronnie Cowan

1173616

registered interest
date	27/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what meetings (a) he, (b) Special Advisers to ministers of his Department, and (c) officials of his Department have attended with representatives of patient groups on the import of cannabis-based products for medicinal use since 1 January 2018.
tabling member constituency	Inverclyde
tabling member printed	Ronnie Cowan
uin	8360
answer	answer is ministerial correction date of answer 04/02/2020 answer text <p>We are aware that some wholesalers and pharmacies have reported challenges in importing a range of unlicensed cannabis-based products for medicinal use. It is clear that for some products, long lead times and delays in receiving export licences from the authorities in the country of manufacture, have led to delays in the supply against prescriptions and pose a potential risk to patients receiving their medicines on time.</p><p>The Department, the Medicines and Healthcare products Regulatory Agency (MHRA), the Home Office, NHS England and NHS Improvement are in the process of agreeing what action can be taken to help alleviate these delays, including exploring mechanisms to allow licensed wholesalers to hold a small reserve stock linked to an evidenced demand by specialist prescribers; and ensuring that the United Kingdom meets its obligations under the Single Convention on Narcotic Drugs. Any changes will be reflected in the guidance published by the MHRA.</p><p>In the meantime, the Home Office and the MHRA are treating all import requests for cannabis-based products for medicinal use as emergency supplies and on receipt of the correct documentation, applicants can expect a decision within a few working days.</p><p>No meetings have taken place with representatives of patient groups concerning the reported delays to imports of cannabis-base products for medicinal use. Officials did meet with patient groups in the development of this policy when the previous Government rescheduled cannabis-based products for medicinal use under the Misuse of Drugs Regulations 2001.</p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 8359 8361 question first answered 04/02/2020 17:26:56 answering member 4380 label Biography information for Jo Churchill
tabling member	4465 label Biography information for Ronnie Cowan

1173619

registered interest
date	27/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the guidance document entitled, The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use in humans specials, published by the Medicines and Healthcare products Regulatory Agency, whether his Department has plans to update that guidance.
tabling member constituency	Inverclyde
tabling member printed	Ronnie Cowan
uin	8361
answer	answer is ministerial correction date of answer 04/02/2020 answer text <p>We are aware that some wholesalers and pharmacies have reported challenges in importing a range of unlicensed cannabis-based products for medicinal use. It is clear that for some products, long lead times and delays in receiving export licences from the authorities in the country of manufacture, have led to delays in the supply against prescriptions and pose a potential risk to patients receiving their medicines on time.</p><p>The Department, the Medicines and Healthcare products Regulatory Agency (MHRA), the Home Office, NHS England and NHS Improvement are in the process of agreeing what action can be taken to help alleviate these delays, including exploring mechanisms to allow licensed wholesalers to hold a small reserve stock linked to an evidenced demand by specialist prescribers; and ensuring that the United Kingdom meets its obligations under the Single Convention on Narcotic Drugs. Any changes will be reflected in the guidance published by the MHRA.</p><p>In the meantime, the Home Office and the MHRA are treating all import requests for cannabis-based products for medicinal use as emergency supplies and on receipt of the correct documentation, applicants can expect a decision within a few working days.</p><p>No meetings have taken place with representatives of patient groups concerning the reported delays to imports of cannabis-base products for medicinal use. Officials did meet with patient groups in the development of this policy when the previous Government rescheduled cannabis-based products for medicinal use under the Misuse of Drugs Regulations 2001.</p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 8359 8360 question first answered 04/02/2020 17:26:56 answering member 4380 label Biography information for Jo Churchill
tabling member	4465 label Biography information for Ronnie Cowan

1173621

registered interest
date	27/01/2020
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what steps her Department is taking to expedite the processes for granting import licences for cannabis-based products for medicinal use.
tabling member constituency	Inverclyde
tabling member printed	Ronnie Cowan
uin	8362
answer	answer is ministerial correction date of answer 04/02/2020 answer text <p>All applications are considered individually on their merits and with regards to our obligation under International Conventions and Domestic law. Applications for importation of CBPMs are already expedited, where documentation and regulatory approval is provided, in recognition of the need to ensure continuity of the supply of unlicensed medicines. Applications for import licences are normally decided within a few working days.</p> answering member constituency North West Hampshire answering member printed Kit Malthouse question first answered 04/02/2020 15:54:19 answering member 4495 label Biography information for Kit Malthouse
tabling member	4465 label Biography information for Ronnie Cowan

1173622

registered interest
date	27/01/2020
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what meetings (a) she, (b) Special Advisers to ministers in her Department, and (c) officials in her Department have attended with representatives of patient groups on the import of cannabis-based products for medicinal use since 1 January 2018.
tabling member constituency	Inverclyde
tabling member printed	Ronnie Cowan
uin	8363
answer	answer is ministerial correction date of answer 04/02/2020 answer text <p>Home Office Ministers, Special Advisers and officials have regular meetings as part of the process of policy development and delivery. As was the case with previous administrations, it is not the Government's practice to provide details of all such meetings.</p> answering member constituency North West Hampshire answering member printed Kit Malthouse question first answered 04/02/2020 15:57:41 answering member 4495 label Biography information for Kit Malthouse
tabling member	4465 label Biography information for Ronnie Cowan